Tola Assefa, Minshore Kirubel Minsamo, Ayele Yohanes, Mekuria Abraham Nigussie
Department of Epidemiology and Biostatistics, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Department of Clinical Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Tuberc Res Treat. 2019 Apr 1;2019:1503219. doi: 10.1155/2019/1503219. eCollection 2019.
Tuberculosis remains a major public health threat throughout the world particularly in developing countries. Evaluating the treatment outcome of tuberculosis and identifying the associated factors should be an integral part of tuberculosis treatment.
The aim of this study was to assess the treatment outcome of tuberculosis and its associated factors among TB patients in the TB clinics of Harar public hospitals, Eastern Ethiopia, 2017.
A retrospective document review was conducted in two public hospitals of Harar town, located 516 km east of Addis Ababa. A systematic random sampling technique was used to select the document of TB patients who were registered in the hospitals from 1st of January, 2011, to 30th of December, 2015. The data were collected using a pretested structured data extraction format. SPSS Version 21 for window was used for data processing. Bivariate and multivariate analysis with 95% confidence interval was employed in order to infer the associations between TB treatment outcome and potential predictor variables.
One thousand two hundred thirty-six registered TB patients' documents were reviewed. Of these, 59.8% were male, 94.2% were urban dwellers, 97% were new cases, 61.2% were presented with pulmonary TB, and 22.8% were HIV positive. Regarding the treatment outcome, 30.4% were cured, 62.1% completed their treatment, 3.9% died, 2.4% were defaulted, and the remaining 1.2% had failed treatment. The overall rate of the treatment success among the patients was 92.5%. In the present study, being female (AOR = 1.89, 95% CI: 1.14 - 3.14), having pretreatment weight of 20 - 29 kg (AOR = 11.03, 95% CI: 1.66 - 73.35), being HIV negative (AOR = 6.50, 95% CI: 3.95 - 10.71), and being new TB patient (AOR = 3.22 95% CI: 1.10 - 9.47) were factors independently associated with successful treatment outcome. On the other hand, being in the age group 54 - 64 years (AOR =10.41, 95% CI: 1.86 - 58.30) and age greater than 65 years (AOR =24.41, 95% CI: 4.19 - 142.33) was associated with unsuccessful TB treatment outcome.
In the current study, the rate of successful TB treatment outcome was acceptable. This rate should be maintained and further improved by designing appropriate monitoring strategies.
结核病仍然是全球尤其是发展中国家主要的公共卫生威胁。评估结核病的治疗效果并确定相关因素应是结核病治疗不可或缺的一部分。
本研究旨在评估2017年埃塞俄比亚东部哈勒尔市公立医院结核病门诊患者的结核病治疗效果及其相关因素。
在位于亚的斯亚贝巴以东516公里的哈勒尔镇的两家公立医院进行回顾性文献审查。采用系统随机抽样技术,选取2011年1月1日至2015年12月31日在医院登记的结核病患者的病历。使用预先测试的结构化数据提取格式收集数据。使用SPSS 21 for window进行数据处理。采用95%置信区间的双变量和多变量分析,以推断结核病治疗效果与潜在预测变量之间的关联。
共审查了1236份登记的结核病患者病历。其中,59.8%为男性,94.2%为城市居民,97%为新病例,61.2%为肺结核患者,22.8%为艾滋病毒阳性。关于治疗效果,30.4%治愈,62.1%完成治疗,3.9%死亡,2.4%失访,其余1.2%治疗失败。患者的总体治疗成功率为92.5%。在本研究中,女性(比值比=1.89,95%置信区间:1.14 - 3.14)、治疗前体重为20 - 29千克(比值比=11.03,95%置信区间:1.66 - 73.35)、艾滋病毒阴性(比值比=6.50,95%置信区间:3.95 - 10.71)以及新结核病患者(比值比=3.22,95%置信区间:1.10 - 9.47)是与治疗成功结果独立相关的因素。另一方面,年龄在54 - 64岁(比值比=10.41,95%置信区间:1.86 - 58.30)和年龄大于65岁(比值比=24.41,95%置信区间:4.19 - 142.33)与结核病治疗失败结果相关。
在本研究中,结核病治疗成功的比例是可以接受的。应通过设计适当的监测策略来维持并进一步提高这一比例。